- Investing Ideas
- Taiwanese Pharmaceuticals & Biotech Price disconnect
Taiwanese Pharmaceuticals & Biotech Price disconnect
Results
7
Stocks which the market has priced substantially different to their cash flows, which could imply risk.
7 companies
TTY Biopharm
Market Cap: NT$19.0b
Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan, the United States, and internationally.
4105
NT$76.50
7D
0.1%
1Y
-1.2%
Standard Chemical & Pharmaceutical
Market Cap: NT$11.1b
Manufactures and sells pharmaceutical products in Taiwan and internationally.
1720
NT$56.40
7D
-1.6%
1Y
6.6%
Cenra
Market Cap: NT$4.7b
Engages in the research and development, manufacture, and sale of generic pharmaceutical and healthcare products for humans and animals.
3716
NT$32.25
7D
-2.4%
1Y
-6.3%
Allied Biotech
Market Cap: NT$2.3b
Engages in the manufacture and sale of carotenoids worldwide.
1780
NT$23.55
7D
-2.5%
1Y
32.7%
TSH Biopharm
Market Cap: NT$1.9b
Develops and markets pharmaceutical products in Taiwan.
8432
NT$50.40
7D
0.8%
1Y
4.3%
Taiwan Advance Bio-Pharmaceutical
Market Cap: NT$822.6m
Operates in the biotechnology industry in China, Germany, USA, Italy, Malaysia, Vietnam, Thailand, Indonesia, Japan, Korea, India, Pakistan, and internationally.
4186
NT$9.14
7D
0%
1Y
-10.8%
Bioray Biotech
Market Cap: NT$575.4m
Engages in the research, development, production, and sells health foods, immune cell products, and precision testing services in Taiwan.
7561
NT$19.45
7D
0%
1Y
-21.3%